Press Releases Archives - Page 5 of 103 - Lupin

BSE 2300.00 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2300.00 NSE 2307.90

Lupin Receives US FDA Approvals for Liraglutide and Glucagon Injectable Products

Lupin Achieves GMP Certification from TGA Australia for Dabhasa API Facility

Lupin Launches Loteprednol Etabonate Ophthalmic Suspension, 0.5% in the United States

Lupin and Zentiva Sign License and Supply Agreement for Commercializing Certolizumab

Lupin Launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% in the United States

Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel

Lupin Carves Out LupinLife Consumer Healthcare

Lupin Launches Prucalopride Tablets in the United States

Lupin Receives Approval from U.S. FDA for Prucalopride Tablets

Lupin and Sino Universal Pharmaceuticals Sign License and Supply Agreement for Tiotropium DPI in China

1 2 … 4 5 6 … 102 103

Search

Hit enter to search or ESC to close